Navigation Links
Unique Hearing Aid Receives Patent Protection
Date:9/2/2008

Revolutionary Device Is Almost Invisible

SHELTON, Conn., Sept. 2 /PRNewswire/ -- Vivatone(R) Hearing Systems received a U.S. patent today on its revolutionary new open-ear hearing device.

Hearing aids traditionally have been bulky devices that plugged up the ear canal, causing a person's voice to sound like they are in a barrel when speaking. Vivatone(R) revolutionized the hearing aid industry in April, 2004 with the introduction of its open-ear hearing aid. Vivatone(R)'s small microphone and digital sound processor fit comfortably behind the ear and connect to the miniature speaker in the center of the person's ear canal.

Because the Vivatone(R) hearing aid leaves the ear canal open, natural sound continues to flow into the ear around the speaker. In addition to the hearing enhancement provided by the digital sound processor, the wearer enjoys the natural sound of their residual hearing. The tiny device is cosmetically appealing and on most people it's almost invisible.

Vivatone(R)'s chairman, Leon C. Hirsch, stated that, "The acceptance of this totally new concept was remarkable. Vivatone(R) was the first company to introduce an open fit, receiver-in-the-ear hearing aid system and patent its development. Subsequently, other companies recognized the value of receiver-in-the-ear and copied Vivatone(R)'s invention. It is gratifying to know that after more than two years of other companies copying Vivatone(R) products, the U.S. Patent and Trademark Office has validated Vivatone(R)'s claims for patent protection on its unique product line."

The growth potential in the hearing aid market is significant. Ten percent of the population of the industrialized world suffers from some form of impairment that can be helped by hearing aids. Despite the potential benefit to these sufferers, 80% of these potential users do not wear hearing aids. Even with only 20% penetration in the United States, annual hearing aid sales are
'/>"/>

SOURCE Vivatone(R) Hearing Systems
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab
2. ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests
3. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
4. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
5. Task Force Recommends Screening for Hearing Loss in All Newborns
6. St. Jude Finds Dancing Hair Cells Are Key to Humans Acute Hearing
7. April 16th Congressional Hearing on Hospital Infections
8. Your Hearing May be at Risk, Says Harvard Mens Health Watch
9. Premier Micronutrient Launches Supplement for Hearing Health
10. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  Mark Farrah Associates (MFA), ... a summary of the 2015 marketplace exchange projections ... According to a recent ASPE ... Evaluation, Department of Health and Human Services) report, ... individual medical plans through the Marketplace as of ...
(Date:12/19/2014)...  In the Friday, December 19 edition of ... Information Technology (HIT) features Konica Minolta, the company announced today. The ... several leading healthcare organizations. In addition to the ... such as New York , Chicago ... , Minneapolis and San Francisco ...
(Date:12/19/2014)... , Dec. 19, 2014 Breckenridge Pharmaceutical, Inc. ... agreement with MSN Laboratories Pvt. Ltd. ( Hyderabad, ... to commercialize several new ANDAs.  Under the terms of ... products exclusively to Breckenridge for the U.S. market, and ... label.  Breckenridge and MSN have agreed to develop an ...
Breaking Medicine Technology:Insights into the Marketplace and Individual Market Growth 2USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2
... /PRNewswire-FirstCall/ -- VION,PHARMACEUTICALS, INC. announced that it presented ... 43rd Annual Meeting of The American,Society of Clinical ... as a single agent in a Phase II ... lung cancer. , The Phase II trial evaluates ...
... Reports EORTC 40983 (EPOC),Intergroup Study Results, CHICAGO, ... the,randomized phase III EORTC 40983 Intergroup study, ... that peri-operative (pre and post,surgery) FOLFOX4 (Eloxatin(R) ... regimen for colon cancer,5-fluorouracil/leucovorin (5-FU/LV)) given to ...
Cached Medicine Technology:Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II,trial of Cloretazine (VNP40101M) in Patients with Relapsed or,Refractory Small Cell Lung Cancer 2Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II,trial of Cloretazine (VNP40101M) in Patients with Relapsed or,Refractory Small Cell Lung Cancer 3Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II,trial of Cloretazine (VNP40101M) in Patients with Relapsed or,Refractory Small Cell Lung Cancer 4The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 2The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 3The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 4The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 5The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 6The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 7The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 8The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 9
(Date:12/22/2014)... December 22, 2014 Physicians in China ... for the treatment of non-Hodgkin’s lymphoma (NHL), according to ... leading global healthcare consulting firm. MabThera is the only ... the most common form of NHL. , According to ... Barriers,” the incidence of NHL in China has been ...
(Date:12/22/2014)... 22, 2014 Explorys, the leader in ... its leadership team: Greg Yarrington as Vice President of ... Patrick Wells as Vice President of Solutions. These new ... new jobs in 2015 to support client demand for ... platform-as-a-service offerings, and growth of its partner network. ...
(Date:12/22/2014)... 2014 In recognition of Veteran’s Day, ... Hero Reward, a local organization that provides services to ... , Located on a couple hundred acres in the ... lodging, world class fishing, hunting, hiking, horseback riding, 4-wheeling, ... several years ago to support U.S. Service men and ...
(Date:12/22/2014)... New York NY (PRWEB) December 22, 2014 ... reports that a federal panel of judges has granted ... lawsuits in the U.S. District Court, Eastern District ... (JPML) issued an order on December 12 to transfer ... actions–pending in 22 districts to the Louisiana court for ...
(Date:12/22/2014)... 2014 Luxury Linen purveyor Peacock Alley ... Dallas to provide logistics and support for one of ... has a long history of giving back to the community ... this year's Toy Drive were Whataburger® and 99.5 The Wolf. ... the holidays. Providing gifts to children who would otherwise not ...
Breaking Medicine News(10 mins):Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 2Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 3Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 3Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 4Health News:Peacock Alley and Community Partners of Dallas Fulfill an Estimated 12,000 Holiday Wishes for Deserving Children 2
... to treat bipolar disorder are more likely to get ... the //Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). ... National Institutes of Health’s (NIH) National Institute of Mental ... 2007 issue of the Archives of General Psychiatry. ...
... it off as just a part of growing older and ... ,“I was increasingly having painful menstrual periods, cramping, ... ,After running some tests, her doctor discovered that Ruma ... women, usually of childbearing age. In addition to painful menstrual ...
... Hindus and Sikhs to be allowed to hold open-air funerals, ... a charity //fighting for the cause being allowed to present ... the Anglo Asian Friendship Society, has been given permission to ... Justice Andrew Collins. ,The development follows a legal ...
... sun appears to impact more on the skin of males than ... exposed a breed of hairless mice to ultraviolet rays from a ... WebMD, The mice underwent eight- to 10-minute tanning sessions three times ... male and female mice skin cancer. ,"We found males ...
... This is one line of thought bra-burning women libbers ... book - Dressed To Kill (Avery Press, revised edition 2001) by ... had come out with claims that wearing a bra throughout ... , The authors claim to have discovered a possible trigger ...
... the chaos created by striking nurses, dentists have thrown in their ... medical card holders stand to lose access to free oral healthcare, ... voting for a withdrawal of support for the Dental Treatment Services ... scheme set up in 1994 to provide free oral ...
Cached Medicine News:Health News:Intensive Psychotherapy Effective in Treating Bipolar Disorder 2Health News:Intensive Psychotherapy Effective in Treating Bipolar Disorder 3Health News:Hope for Ending the Pain, Infertility of Endometriosis? 2Health News:Hope for Ending the Pain, Infertility of Endometriosis? 3Health News:Breast Cancer and Bra Wearing: Possibly Linked 2
... VenaCure Laser Vein Treatment. It is estimated ... worldwide have varicose veins. In the United States, ... of 60 suffer from painful and unsightly venous ... the capabilities of vascular therapy for the treatment ...
ELVeS is a new minimally-invasive laser treatment for patients with superficial vein reflux of the greater saphenous vein. The ELVeS laser treatment offers your patients an effective out-patient alt...
... technology provides practitioners with the ability to treat ... permanent hair reduction on all skin types and ... the practitioner to instantly switch to a 3, ... a simple twist of the handpiece dial while ...
... people are diagnosed with varicose veins every ... never seek treament and are apprehensive of ... them an effective alternative to conventional therapies., ... hook phlebectomy), is considered a laborious procedure ...
Medicine Products: